Health In Tech, Inc.
TechnologyNASDAQ:HIT · NASDAQ Capital Market
+$0.01 today
Vol 0.11M · Avg 0.38M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
7.5%
avg 15.2%
ROIC
6.5%
avg 10.7%
ROA
5.5%
avg 7.9%
Analysis
ROE is currently the strongest return metric at 7.5% versus its period average of 15.2%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Tim Johnson | Founder, Chief Executive Officer & Chairman | $420,000.00 | — | 59 | $23.47M | 43.60% |
Jonathan Lockett | Chief Strategy Officer | $401,000.00 | — | 64 | $143,539.00 | 0.27% |
Julia Qian | Chief Financial Officer & Director | $360,000.00 | — | 50 | $9.08M | 16.87% |
Dustin Plantholt | Chief AI & Marketing Officer | $280,632.00 | — | 42 | $64,000.00 | 0.12% |
Sri Rajagopalan | Chief Technology Officer | $251,296.00 | — | 57 | $20,000.00 | 0.04% |
Glenn Hillyer | Senior Vice President of Sales Partner Relations | — | — | 61 | — | — |
John McStravock | General Counsel | — | — | — | $5,000.00 | <0.01% |
Michael Clarkson | Chief Information Security Officer | — | — | 51 | $8,000.00 | 0.01% |
Zain Hasan | Chief Growth Officer | — | — | 38 | $212,347.00 | 0.39% |
Lori Babcock | Chief of Staff | — | — | 61 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +137.1% | +188.7% (2yr)2 analysts |
| Revenue | N/A | N/A | +79.4% | +53.4% (2yr)2 analysts |
| Net Income | N/A | N/A | +152.2% | +174.6% (2yr)2 analysts |
| EBIT | N/A | N/A | +95.2% | +107.5% (2yr)2 analysts |
Analysis
Recent growth has been strongest in Net Income at +152.2% over three years. Forward estimates point to EPS at +188.7% (2yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Viant Technology Inc.
NASDAQ:DSP
$728.37M
Silvaco Group, Inc. Common Stock
NASDAQ:SVCO
$397.73M
TROOPS, Inc.
NASDAQ:TROO
$304.18M
CoreCard Corporation
CCRD
$183.90M
Robot Consulting Co., Ltd. ADS
LAWR
$172.35M
Teads Holding Co.
NASDAQ:TEAD
$127.06M
Expensify, Inc.
NASDAQ:EXFY
$121.51M
Stem, Inc.
NYSE:STEM
$65.48M
Arrive AI Inc.
ARAI
$15.67M
X3 Holdings Co., Ltd.
XTKG
$575,474.00
Who manages HIT?
Health In Tech, Inc. (HIT) lists 10 active executives. The top listed executive is Dustin Plantholt, Chief AI & Marketing Officer.
Are HIT insiders buying or selling?
Recent insider activity shows net buying of $261,019.27.
Explore More
Continue the stock analysis
Jump to another research area for this company.